Actively Recruiting
Clinical Features Associated With Restless Legs Syndrome : Clin-RLS
Led by University Hospital, Montpellier · Updated on 2021-09-24
2000
Participants Needed
1
Research Sites
52 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are investigating the clinical features and progression of Restless Legs Syndrome (RLS), a chronic neurological condition causing an urge to move the legs at night, leading to sleep problems, daytime sleepiness, and reduced quality of life. This observational study aims to assess how RLS symptom severity changes over time in relation to different RLS types, other health conditions, and medications used by patients, involving members of French and European RLS associations. The study does not involve experimental treatments but observes patients who are already diagnosed with RLS and are members of patient associations. It will collect clinical and biological data as well as information on current RLS medications. The study will measure symptom severity and related impacts using various rating scales and questionnaires during scheduled assessments. Participants will be asked to complete several rating scales including the International Restless Legs Syndrome Study Group rating scale and questionnaires assessing sleep issues, depression, quality of life, and fall risk. The study will monitor these measures over time to understand symptom progression. Participants must be adults, able to communicate in French, and affiliated with social security. The study duration extends through to 2027, with ongoing data collection and follow-up.
CONDITIONS
Brief Title
Clinical Features Associated With Restless Legs Syndrome.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult subjects
- Diagnosed with restless legs syndrome
- Member of a restless legs syndrome patient association
- Able to speak and understand French
- Able to understand the study details
- Signed written informed consent
- Affiliated with social security
You will not qualify if you...
- Subjects who are vulnerable, such as those deprived of liberty or under legal guardianship or trusteeship
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to approximately 3 years
Participants who have restless legs syndrome are observed to study the clinical course of the condition, including clinical and biological factors as well as treatments taken.
Visits scheduled as needed to assess condition
Trial Site Locations
Total: 1 location
1
Uhmontpellier
Montpellier, France, 34295
Actively Recruiting
Research Team
S
Sofiene Chenini, MD
Y
Yves DAUVILLIERS, MD PhD
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here